P. A. Ascierto, G. A. Mcarthur, B. Dreno, V. Atkinson, G. Liszkay et al., Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial, Lancet Oncol, vol.17, pp.1248-1260, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01407426

L. Peuvrel, G. Quereux, M. Saint-jean, A. Brocard, J. M. Nguyen et al., Profile of vemurafenib-induced severe skin toxicities, J Eur Acad Dermatol Venereol, vol.30, pp.250-257, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01819814

J. T. Yorio, S. R. Mays, A. M. Ciurea, P. R. Cohen, W. L. Wang et al., Case of vemurafenib-induced Sweet's syndrome, J Dermatol, vol.41, pp.817-820, 2014.

P. Pattanaprichakul, M. T. Tetzlaff, W. J. Lapolla, C. A. Torres-cabala, M. Duvic et al., Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma, J Cutan Pathol, vol.41, pp.326-328, 2014.

F. Herms, N. Franck, N. Kramkimel, F. Fichel, L. Delaval et al., Neutrophilic eccrine hidradenitis in two patients treated with BRAF inhibitors: a new cutaneous adverse event, Br J Dermatol, vol.176, pp.1645-1648, 2017.

L. Zimmer, E. Livingstone, U. Hillen, S. Domkes, A. Becker et al., Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management, Arch Dermatol, vol.148, pp.357-361, 2012.

N. S. Ramani, J. L. Curry, J. Kapil, R. P. Rapini, M. T. Tetzlaff et al., Panniculitis with necrotizing granulomata in a patient on BRAF inhibitor (dabrafenib) therapy for metastatic melanoma, Am J Dermatopathol, vol.37, pp.96-99, 2015.

L. Leal, E. Agut-busquet, J. Romani, M. Sabat, M. Yebenes et al., Cutaneous granulomatous panniculitis and sarcoidal granulomatous papular eruption in a patient with metastatic melanoma treated with a BRAF inhibitor, J Dermatol, vol.43, pp.715-716, 2016.

R. M. Anforth, T. C. Blumetti, R. F. Kefford, R. Sharma, R. A. Scolyer et al., Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma, Br J Dermatol, vol.167, pp.1153-1160, 2012.

R. Mossner, L. Zimmer, C. Berking, C. Hoeller, C. Loquai et al., Erythema nodosum-like lesions during BRAF inhibitor therapy: report on 16 new cases and review of the literature, J Eur Acad Dermatol Venereol, vol.29, pp.1797-1806, 2015.